Ironwood Pharmaceuticals, Inc. (IRWD) Stock Grade

About Ironwood Pharmaceuticals, Inc.'s fundamentals

Ironwood Pharmaceuticals is a specialty pharmaceutical manufacturer with a market capitalization of $546.7 million, currently trading at a P/E ratio of 22.8. The company is experiencing revenue headwinds, with year-over-year revenue declining 15.7%, though it maintains a positive net margin of 8.1%, indicating profitability despite the sales contraction. The company does not pay a dividend and has not disclosed a return on equity metric, suggesting either recent losses or insufficient equity data for calculation.